Objective: To evaluate the expression of glucose transporters (Gluts) 1 and 3 in Hodgkin and nonHodgkin lymphoma and to assess the association between their expression and the tumor intensity on 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET).
Methods: All 31 lymphoma patients in whom the histologic diagnosis was made and who had also undergone a prechemotherapy PET scan at our institution between June 2001 and December 2005 were included in this retrospective study. The percentage of tumor cells in the various lymphoma subtypes was estimated by comparison of hematoxylin and eosin stain with a lineage-associated immunohistochemical stain on the same block of tissue. Tissue specimens were stained with Glut1 and Glut3 antibodies. The percentages of Glut1+ and Glut3+ cells in the entire cell population (lymphoma cells and nonlymphomatous cells) and among the lymphoma cells were estimated. FDG PET images were reviewed and the tumor intensity was assessed by calculating the maximum standard uptake value (SUVmax). Correlation coefficients between SUVmax and the percentage of Glut1+ and Glut3+ cells in the entire cell population were calculated.
Results: In all 31 cases, tumors were visible on FDG PET and positive for Glut1 and Glut3. The correlation between the percentage of Glut1+ cells and SUVmax was statistically significant across all 31 cases (r = 0.73, P<0.0001, 95% confidence interval: 0.50-0.86) and across the 25 cases of nonHodgkin lymphoma (r = 0.71, P<0.0001, 95% confidence interval: 0.44-0.87). There was no statistically significant correlation between the percentage of Glut3+ cells and SUVmax. More importantly, in 16 of 31 cases (52%), only nonlymphomatous, benign cells expressed Glut1 or Glut3.
Conclusion: Intensity of lymphoma on FDG PET is likely associated with Glut1 expression. The nonlymphomatous, benign cells may play an important role in visualization of lymphoma on FDG PET.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/MNM.0b013e32832cc295 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
METTL14 Mediates m6A methylation to improve osteogenesis under oxidative stress condition.
Redox Rep
December 2025
Department of Clinical Laboratory, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China.
Objectives: Bone remodeling imbalance contributes to osteoporosis. Though current medications enhance osteoblast involvement in bone formation, the underlying pathways remain unclear. This study was aimed to explore the pathways involved in bone formation by osteoblasts, we investigate the protective role of glycolysis and N6-methyladenosine methylation (m6A) against oxidative stress-induced impairment of osteogenesis in MC3T3-E1 cells.
View Article and Find Full Text PDFPlacental expression of GLUT-1, GLUT-3, and GLUT-4 mRNA and transcriptome profiling in pregnant women with diabetes.
J Diabetes Investig
December 2024
Department of Reproduction, Poznan University of Medical Sciences, Poznan, Poland.
Article Synopsis
- The study investigates how glucose transporter proteins (GLUTs) in the placenta are expressed in pregnant women with type 1 diabetes, early gestational diabetes (eGDM), and healthy controls, aiming to find correlations with clinical parameters.
- Significant decreases in GLUT-3 and GLUT-4 mRNA expression were observed in patients with diabetes, especially eGDM, and these changes were linked to lower neonatal birth weights and various glycemic factors.
- The research also uncovered substantial transcriptomic changes in women with diabetes, indicating a complex relationship between GLUT expression, neonatal outcomes, and glycemic control.
Maternal chitosan oligosaccharide supplementation during late gestation and lactation optimizes placental function in sows and intestinal function in 21-day-old IUGR suckling piglets.
Front Vet Sci
November 2024
Animal Nutrition Institute, Sichuan Agricultural University, Chengdu, China.
Article Synopsis
- - Maternal dietary supplementation with chitosan oligosaccharide (COS) during late gestation and lactation significantly reduced stillbirths and mummies in piglets, indicating improved productivity for sows.
- - Analysis showed that COS supplementation enhanced the expression of key mRNAs in the placenta of IUGR piglets, pointing to better placental function and reduced oxidative stress.
- - Additionally, the intestinal health of IUGR piglets from COS sows improved, evidenced by increased mRNA and protein levels in the jejunum, suggesting better immune status and overall growth potential.
Hesperidin Suppressed Colorectal Cancer through Inhibition of Glycolysis.
Chin J Integr Med
November 2024
Department of Medical Oncology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200062, China.
Objective: To explore the role of the natural compound hesperidin in glycolysis, the key ratelimiting enzyme, in colorectal cancer (CRC) cell lines.
Methods: In vitro, HCT116 and SW620 were treated with different doses of hesperidin (0-500 µmol/L), cell counting kit-8 and colone formation assays were utilized to detected inhibition effect of hesperidin on CRC cell lines. Transwell and wound healing assays were performed to detect the ability of hesperidin (0, 25, 50 and 75 µmol/L) to migrate CRC cells.
A novel approach to regulate glucose uptake in an anaplastic thyroid cancer cell line.
Endocr Connect
November 2024
M Hedayati, Tehran, 1985717413, United Kingdom of Great Britain and Northern Ireland.
Aims And Background: Curcumin's function in affecting cancer metabolic reprogramming remains poorly understood. Herein, we aimed to elucidate a novel link between Curcumin and the glucose uptake metabolism and glucose transporters (GLUTs) status in SW1736 cell line derived from anaplastic thyroid cancer.
Materials And Methods: TheMTT test and flow cytometry was employed to test cell viability and cell death.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!